Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark
Department of Pediatrics, Rigshospitalet, Copenhagen, Denmark.
J Med Genet. 2023 Sep;60(9):842-849. doi: 10.1136/jmg-2022-108982. Epub 2023 Apr 5.
Studies suggest that Wilms tumours (WT) are caused by underlying genetic (5%-10%) and epigenetic (2%-29%) mechanisms, yet studies covering both aspects are sparse.
We performed prospective whole-genome sequencing of germline DNA in Danish children diagnosed with WT from 2016 to 2021, and linked genotypes to deep phenotypes.
Of 24 patients (58% female), 3 (13%, all female) harboured pathogenic germline variants in WT risk genes ( and ). Only one patient had a family history of WT (3 cases), segregating with the variant. Epigenetic testing revealed one (4%) additional patient (female) with uniparental disomy of chromosome 11 and Beckwith-Wiedemann syndrome (BWS). We observed a tendency of higher methylation of the BWS-related imprinting centre 1 in patients with WT than in healthy controls. Three patients (13%, all female) with bilateral tumours and/or features of BWS had higher birth weights (4780 g vs 3575 g; p=0.002). We observed more patients with macrosomia (>4250 g, n=5, all female) than expected (OR 9.98 (95% CI 2.56 to 34.66)). Genes involved in early kidney development were enriched in our constrained gene analysis, including both known (, ) and candidate () WT predisposition genes. WT predisposing variants, BWS and/or macrosomia (n=8, all female) were more common in female patients than male patients (p=0.01).
We find that most females (57%) and 33% of all patients with WT had either a genetic or another indicator of WT predisposition. This emphasises the need for scrutiny when diagnosing patients with WT, as early detection of underlying predisposition may impact treatment, follow-up and genetic counselling.
研究表明,威尔姆斯瘤(WT)是由潜在的遗传(5%-10%)和表观遗传(2%-29%)机制引起的,但涵盖这两个方面的研究很少。
我们对 2016 年至 2021 年期间丹麦诊断为 WT 的儿童进行了前瞻性全基因组种系 DNA 测序,并将基因型与深度表型相关联。
24 名患者中(58%为女性),3 名(13%,均为女性)携带 WT 风险基因(和)的致病性种系变异。只有一名患者(3 例)有 WT 的家族史(与变异共分离)。表观遗传学检测显示,1 名(4%)额外的患者(女性)存在 11 号染色体单亲二体性和贝克威斯-威德曼综合征(BWS)。我们观察到 WT 患者中与 BWS 相关的印迹中心 1 的甲基化程度高于健康对照组的趋势。3 名(13%,均为女性)双侧肿瘤和/或 BWS 特征的患者出生体重较高(4780 g 比 3575 g;p=0.002)。我们观察到更多的患者出现巨大儿(>4250 g,n=5,均为女性),这比预期的要多(OR 9.98(95% CI 2.56 至 34.66))。我们的约束基因分析中富集了参与早期肾脏发育的基因,包括已知的(、)和候选的()WT 易感性基因。WT 易感性变异、BWS 和/或巨大儿(n=8,均为女性)在女性患者中比男性患者更常见(p=0.01)。
我们发现大多数女性(57%)和所有 WT 患者的 33%要么有遗传易感性,要么有 WT 易感性的其他指标。这强调了在诊断 WT 患者时需要仔细检查,因为早期发现潜在的易感性可能会影响治疗、随访和遗传咨询。